SEC Form 4 · accession 0001127602-15-026834
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wayne S DeVeydt
Officer — EVP & Chief Financial Officer
Period of report
Sep 8, 2015
Accepted (ET)
Sep 10, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 8, 2015 | M | 6,969 | $61.88 | A | 76,576 | D | |
| Common StockF2 | Sep 8, 2015 | S | 5,269 | $143.82 | D | 71,307 | D | |
| Common StockF3 | Sep 8, 2015 | S | 1,700 | $144.55 | D | 69,607 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $61.88 | Sep 8, 2015 | M | 6,969 | D | — | Mar 1, 2020 | Common Stock | 6,969 | 6,969 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2015.
- F2This transaction was executed in multiple trades at prices ranging from $143.19 to $144.15. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $144.33 to $144.82. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4The option, representing a right to purchase a total of 41,811 shares, became exercisable in three equal semi-annual installments of 6,968 shares each and three equal semi-annual installments of 6,969 shares each beginning on September 1, 2013, which was the six-month anniversary of the date on which the option was granted.